MYH9 and APOL1 are both associated with sickle cell disease nephropathy - Wikidata - wikimedia - TriplyDB

MYH9 and APOL1 are both associated with sickle cell disease nephropathy

MYH9 and APOL1 are both associated with sickle cell disease nephropathy

http://www.wikidata.org/entity/Q37451162

about

Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans Ethnic Differences in Childhood Nephrotic Syndrome APOL1 Kidney Disease Risk Variants: An Evolving Landscape Genomic approaches to identifying targets for treating β hemoglobinopathies Hypertension and chronic kidney disease: controversies in pathogenesis and treatment Sickle cell disease and H3Africa: enhancing genomic research on cardiovascular diseases in African patients APOL1 and nephropathy progression in populations of African ancestry APOL1 kidney risk alleles: population genetics and disease associations In vivo Modeling Implicates APOL1 in Nephropathy: Evidence for Dominant Negative Effects and Epistasis under Anemic Stress Lack of Association of the APOL1 G3 Haplotype in African Americans with ESRD Perspectives in Genetics and Sickle Cell Disease Prevention in Africa: Beyond the Preliminary Data from Cameroon Hydroxyurea is associated with lower prevalence of albuminuria in adults with sickle cell disease Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.The prevalence of hypertension and abnormal kidney function in children with sickle cell disease -a cross sectional review APOL1 null alleles from a rural village in India do not correlate with glomerulosclerosis.Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.Proteomics analysis of the non-muscle myosin heavy chain IIa-enriched actin-myosin complex reveals multiple functions within the podocyte.Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.The new era of APOL1-associated glomerulosclerosis.Genetic modifiers of sickle cell disease Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.Genetic variants and cell-free hemoglobin processing in sickle cell nephropathy.Genetic Modifiers of White Blood Cell Count, Albuminuria and Glomerular Filtration Rate in Children with Sickle Cell Anemia.APOL1 Risk Alleles Are Associated with Exaggerated Age-Related Changes in Glomerular Number and Volume in African-American Adults: An Autopsy Study.Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure Background strain and the differential susceptibility of podocyte-specific deletion of Myh9 on murine models of experimental glomerulosclerosis and HIV nephropathy Gene-gene interactions in APOL1-associated nephropathy.The search for genetic modifiers of disease severity in the β-hemoglobinopathies.Sickle cell disease: renal manifestations and mechanisms Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target.Minireview: Genetic basis of heterogeneity and severity in sickle cell disease.Focal Segmental Glomerulosclerosis.Genetics of Sickle Cell-Associated Cardiovascular Disease: An Expert Review with Lessons Learned in Africa.Congolese children with sickle cell trait may exhibit glomerular hyperfiltration: A case control study.Integrating APOL1 Gene Variants Into Renal Transplantation: Considerations Arising From the American Society of Transplantation Expert Conference.APOL1 Renal-Risk Variants Induce Mitochondrial Dysfunction.Therapeutics for APOL1 nephropathies: putting out the fire in the podocyte.Apolipoprotein L1 Variants and Blood Pressure Traits in African Americans.Sickle Cell Trait and the Risk of ESRD in Blacks.Brief Report: APOL1 Renal Risk Variants Are Associated With Chronic Kidney Disease in Children and Youth With Perinatal HIV Infection.

P2860

Q24621889-5C763DA5-8B0A-4A57-AFD6-6F1425E2E2EF Q26752347-11AAAFFE-5F5E-41E0-A774-0AFB6D91E3D2 Q26799191-7C0830F7-39C2-41D3-9227-C2CB05FCB98C Q26799214-6FE18E05-C083-446D-A68D-5298C7C5E1FB Q26851271-C92A4E6E-5412-4548-B545-C00519D4FEB0 Q27016104-9FC363B7-B4A6-4A80-B4B8-95729C6CB6B8 Q27022275-E04C5077-4A24-4203-9DB0-2FC0DD3E18BC Q27024261-F0BD729B-3EB4-4767-A2E9-F0FB0295474F Q28546164-480AB6CB-705C-4828-9127-06D96EB0FCB8 Q30359344-EB785020-7118-4FF0-B674-20E24E3EC20B Q30965927-53435782-70EF-4B74-850F-FFD49758E409 Q33684601-A83E496B-8373-485F-B4E3-61DC4F163623 Q34455119-11DD2B4A-EFA4-4B2A-A67F-6B33BEA8C8FB Q34509369-53779579-8066-4B73-96A7-48573AB1DD74 Q34540191-EB6E13F7-90E5-4680-96B9-343A062B0242 Q34797825-0B83AFB7-B669-4BC9-B4BD-9C573DCF7540 Q35192019-08913220-3D48-4C03-A78E-2FABDF792E70 Q35528147-0C65DA5D-8581-43D5-ACB0-B27BD8599A43 Q35861466-FF923ED7-86D4-4BFA-A739-EFD61CEB0BAF Q36035471-C9A102FA-7CDD-4091-8B7A-D6EA0B741731 Q36109136-E8269B4B-CF59-4258-B1C9-26721ADD88A1 Q36115647-9210EA57-C7ED-483D-9646-2442EE2E3EF6 Q36155283-1E9B99BC-103E-49E8-A6E5-302A65F263C8 Q36314923-C752EBC2-135F-45DD-BBA7-C3BC9B8DBB13 Q36668912-27D9DDB4-4C81-4451-9A57-6AE85E01A48C Q37001088-BF005DAD-BAB5-45CE-B4E1-B08BF9F34F2D Q37609715-A2B4979E-A801-4137-BD97-AC15731A2279 Q38048766-EB6A6541-04C6-4BA0-8BB5-DE514192E7D7 Q38350669-0B426AA0-2824-460A-9B5F-1B3497D68867 Q38682842-B3001978-A818-43FB-BE32-07C3BD66B23E Q38758451-2587A637-E45A-4BF9-975C-58B342BD5C6F Q38938623-447ED9F7-8206-4FB7-BFFC-90D00A28292E Q38977617-ACC776C1-47EA-46B9-996E-9196AB07AA73 Q39012812-2510795A-E47F-4385-9598-946E2CA8B967 Q39084175-663E9020-7E8D-4DC4-91EB-87986941581F Q39207538-14B6B447-FFC4-4D79-9670-4A8923CB07BB Q39229321-40E8329D-338A-4D15-B402-2244AF614B9A Q40277101-47A104C3-9E30-4118-A0A5-0D2FCB063E9B Q40298866-597E4E69-F54A-4EA7-90D4-B725235EF592 Q40732344-50817BAF-6AB2-4D77-9F12-8BD4737CBCDC

P2860

MYH9 and APOL1 are both associated with sickle cell disease nephropathy

http://www.wikidata.org/entity/Q37451162

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 13 September 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

MYH9 and APOL1 are both associated with sickle cell disease nephropathy

@en

MYH9 and APOL1 are both associated with sickle cell disease nephropathy.

@nl

type

label

MYH9 and APOL1 are both associated with sickle cell disease nephropathy

@en

MYH9 and APOL1 are both associated with sickle cell disease nephropathy.

@nl

prefLabel

MYH9 and APOL1 are both associated with sickle cell disease nephropathy

@en

MYH9 and APOL1 are both associated with sickle cell disease nephropathy.

@nl

P1433

Q37451162-ACEAA81B-660F-4BD9-ACC6-B1E3194BD574

P1476

Q37451162-5809FE63-7534-4A6F-BC84-96370B13F75A

P2093

Q37451162-1D15E4BF-5D8F-41E5-A9B6-971BF235E729

Q37451162-2922F8FA-8F1A-466F-96FF-D715F5CBFF55

Q37451162-32E418EC-10BA-41D4-8851-2C9DAB5579D9

Q37451162-708B7F94-7C57-4CED-83F9-6F7AA03E2B3B

Q37451162-7E494570-74CE-4F1F-8989-D62DE4163FAD

Q37451162-A63FC8C4-07A3-4F4F-942E-54C22D5E5BBA

Q37451162-AAB185F4-6B0E-4410-9EB6-0DCBFC4A5211

Q37451162-ED3C6FE2-7294-46A6-B4F0-D2C6562A97AD

P2860

Q37451162-02621F6D-DC85-4C29-876F-1D782EED6B4E

Q37451162-064127D7-9040-4E61-BDE5-F3BFED2727FE

Q37451162-088B86AA-7C8B-47B0-BE57-168EC16DE9C3

Q37451162-12DF2001-81DF-46CD-9CD9-A4F06CA90663

Q37451162-21DE53A8-4F29-4C2B-B8EC-76A9276E1AE6

Q37451162-27B2746F-16FC-4C6C-8C17-3F558ED33F8D

Q37451162-4006AB4E-D632-481C-9A86-D65B177A3783

Q37451162-4A59B776-7C19-44E6-BEFA-3265E1CB5168

Q37451162-4DCE361D-605A-473C-AAE8-AFEFE5C570DD

Q37451162-55877BA7-9C42-449E-A6D7-5A80145BEBFB

P304

Q37451162-460CEBFB-DD90-4D76-8BCD-187D8941799A

P31

Q37451162-32545133-2D72-4255-8238-2100A37E742B

P356

Q37451162-ABC588AE-2F8F-42E0-A662-1E3D882BD891

P407

Q37451162-505A0904-73B3-403E-9637-A623E81278A4

P433

Q37451162-5058CC0C-CD0F-4F2D-9704-94069402ECA5

P478

Q37451162-732F2C7F-78F9-4B64-A067-03AF098E6336

P50

Q37451162-D9DA9FFC-5358-45E4-A71B-382B8DA88DAB

P577

Q37451162-8E49BF44-9A2C-4EAE-9FDF-A16AB7FBE36F

P5875

Q37451162-078F22FF-2870-413C-A90D-5C25889B857D

P698

Q37451162-EA6EA80B-D690-41DB-9C56-3FB9D2D43471

P921

Q37451162-19E85E43-B4B6-4A3D-A816-BF32F61DD41D

P932

Q37451162-E2C06A0D-DADF-43FF-86C8-94FBC25B5A85

P356

J.1365-2141.2011.08832.X

P1433

British Journal of Haematology

P1476

MYH9 and APOL1 are both associated with sickle cell disease nephropathy

@en

P2093

Emmanuel C Okocha

http://www.w3.org/2001/XMLSchema#string

Eugene P Orringer

http://www.w3.org/2001/XMLSchema#string

James R Eckman

http://www.w3.org/2001/XMLSchema#string

Jude C Jonassaint

http://www.w3.org/2001/XMLSchema#string

Karen Soldano

http://www.w3.org/2001/XMLSchema#string

Laura M De Castro

http://www.w3.org/2001/XMLSchema#string

Marilyn J Telen

http://www.w3.org/2001/XMLSchema#string

Melanie E Garrett

http://www.w3.org/2001/XMLSchema#string

P2860

Population structure and eigenanalysis

African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

MYH9 is associated with nondiabetic end-stage renal disease in African Americans

Sickle-cell disease

Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium

Score tests for association between traits and haplotypes when linkage phase is ambiguous

Nitric oxide-dependent generation of reactive species in sickle cell disease. Actin tyrosine induces defective cytoskeletal polymerization.

P304

386-394

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2141.2011.08832.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

155

http://www.w3.org/2001/XMLSchema#string

P50

Allison Ashley-Koch

P577

2011-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51641188

http://www.w3.org/2001/XMLSchema#string

P698

21910715

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

3885232

http://www.w3.org/2001/XMLSchema#string